Harmony Biosciences Holdings (HRMY)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.98B
Last updated: Nov 17, 2026 at 11:05 AM ET
Harmony Biosciences Holdings (HRMY) Competitors
The companies most similar to Harmony Biosciences Holdings are Biohaven (BHVN), Zenas BioPharma, Inc. Common Stock (ZBIO) and Beam Therapeutics (BEAM). By market cap, Harmony Biosciences Holdings ranks 7th of the 13 companies on this page; Legend Biotech (LEGN) is the largest at $3.39B.
Peer Comparison
HRMY's ROIC of 13.7% is above the peer median of -29.0%, and its revenue growth of 12.3% is above the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Harmony Biosciences Holdings (HRMY) | $1.98B | 9.6x | 1.9x | 18.0% | 13.7% | 12.3% | 0.00% |
| Biohaven Ltd. (BHVN) | $2.09B | N/A | N/A | 0.0% | -315.9% | 0.0% | 0.00% |
| Zenas BioPharma, Inc. Common Stock (ZBIO) | $1.90B | N/A | 168.0x | 0.0% | -104.3% | -100.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| MBX Biosciences, Inc. Common Stock (MBX) | $2.78B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pharvaris BV (PHVS) | $2.36B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Alto Neuroscience, Inc. (ANRO) | $1.18B | N/A | N/A | 0.0% | -23.5% | 0.0% | 0.00% |
| Maravai Lifesciences Holdings Inc (MRVI) | $1.96B | N/A | 5.2x | -30.8% | -28.3% | 10.1% | 0.00% |
| Forte Biosciences Inc (FBRX) | $1.63B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Fortrea Holdings Inc. (FTRE) | $1.95B | 26.0x | 0.7x | -2.6% | 1.8% | -1.4% | 0.00% |
| Palvella Therapeutics, Inc (PVLA) | $2.23B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vor Biopharma Inc (VOR) | $1.19B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $2.02B | 146.3x | 5.2x | 0.0% | -29.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Harmony Biosciences Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Biohaven Ltd. (BHVN) | Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders... | BHVN competitors |
| Zenas BioPharma, Inc. Common Stock (ZBIO) | Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based... | ZBIO competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| MBX Biosciences, Inc. Common Stock (MBX) | MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment... | MBX competitors |
| Pharvaris BV (PHVS) | Pharvaris NV, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. | PHVS competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Alto Neuroscience, Inc. (ANRO) | Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. | ANRO competitors |
| Maravai Lifesciences Holdings Inc (MRVI) | Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines... | MRVI competitors |
| Forte Biosciences Inc (FBRX) | Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California. | |
| Fortrea Holdings Inc. (FTRE) | Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. | FTRE competitors |
| Palvella Therapeutics, Inc (PVLA) | Palvella Therapeutics, Inc. is an innovative biotechnology firm dedicated to developing transformative therapies for rare genetic disorders resulting from... | PVLA competitors |
| Vor Biopharma Inc (VOR) | Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. | VOR competitors |
Frequently Asked Questions About HRMY
Who are Harmony Biosciences Holdings' main competitors?
The companies most similar to Harmony Biosciences Holdings include Biohaven (BHVN), Zenas BioPharma, Inc. Common Stock (ZBIO), Beam Therapeutics (BEAM), MBX Biosciences, Inc. Common Stock (MBX) and Pharvaris BV (PHVS), listed from the closest match.
Who is Harmony Biosciences Holdings' biggest competitor?
Legend Biotech (LEGN) is the largest of the similar companies at $3.39B; Biohaven (BHVN) is the closest match by business profile, size, sector and industry.
How does HRMY stock compare with its competitors?
HRMY's P/E is 9.6x against a peer median of 146.3x; its P/S is 1.9x against a peer median of 5.2x; its net margin is 18.0% against a peer median of 0.0%.
Which of Harmony Biosciences Holdings' competitors pays a higher dividend?
Harmony Biosciences Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Harmony Biosciences Holdings bigger than its competitors?
No. Harmony Biosciences Holdings is 7th by market cap among the 13 companies on this page; the largest is Legend Biotech (LEGN) at $3.39B.
HRMY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts